학술논문

Lorlatinib and capmatinib in a ROS1-rearranged NSCLC with MET-driven resistance: tumor response and evolution
Document Type
Article
Source
In: npj Precision Oncology. (npj Precision Oncology, December 2023, 7(1))
Subject
Language
English
ISSN
2397768X